Regeneron Pharmaceuticals Inc.
Dupixent® (dupilumab) Approved in the European Union as the First and[...]
02/23/2023 | Press release | Distributed by Public on 02/23/2023 00:05
Please select the service you want to use:
Smartlinks | AXA SA | Company News | Public Companies | Multiline Insurance and Brokers | Borsa Italiana | London Stock Exchange (LSE) | Frankfurt Stock Exchange | Six Swiss Exchange | Vienna Stock Exchange | Berlin Stock Exchange | Dusseldorf Stock Exchange | Hamburg Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | Bolsa Mexicana de Valores (BMV) | Budapest Stock Exchange | OTC Markets | Tradegate Exchange | XETRA | Euronext Paris | Cboe BXE Europe | Cboe CXE Europe | Cboe Off Exchange | Aquis Exchange | SIGMA X MTF | EuroTLX | Bolsa Institucional de Valores (BIVA) | Equiduct | Euronext Block MTF | Hannover Stock Exchange | Turquoise
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact